Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Therapy Related Leukemia

Increase therapy-related leukemia secondary to breast cancer

Leukemia volume 14, pages 1014–1017 (2000)Cite this article

Abstract

Therapy-related leukemia associated with chemotherapy, particularly alkylating agents and topoisomerase II inhibitors, are being reported with increasing frequency in the literature mainly after breast cancer. We also observed an increasing number of such leukemias in the data base of the specialized registry of hematological malignancies of the Côte d'Or department. Between 1980 and 1998, 156 AML and RAEB-t were registered in women in Côte d'Or. Among them, 12 occurred in women with breast cancer history (7.7%). Analysis by period of time shows a significant increase in the proportion of therapy-related leukemia secondary to breast cancer (P < 0.02). chemotherapy including topoisomerase ii inhibitors was used in 10 cases in which mitoxantrone was used in eight cases. in these eight cases, leukemia had clinical and biological characteristics usually described with topoisomerase ii inhibitors but 44% were promyelocytic sub-type with the t(15;17) specific karyotypic abnormality. these data on a well-defined population demonstrate the increased proportion of therapy-related leukemia secondary to breast cancer, probably due to the use of mitoxantrone.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Whitlock JA, Greer JP, Lukens JN . Epipodophyllotoxin-relatedleukemia. Identification of a new subset of secondary leukemia Cancer 1991 68: 600–604

    Article  CAS  Google Scholar 

  2. Pedersen Bjergaard J, Specht L, Larsen SO, Ersbil J, Struck J, Hansen MM, Hanse HH, Nissen NI . Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy Lancet 1987 2: 83–88

    Article  CAS  Google Scholar 

  3. Curtis RE, Boice JD Jr, Moloney WC, Ries LG, Flannery JT . Leukemia following chemotherapy for breast cancer Cancer Res 1990 50: 2741–2746

    CAS  PubMed  Google Scholar 

  4. Thirman MJ, Larson RA . Therapy-related myeloid leukemia Hematol Oncol Clin North Am 1996 10: 293–320

    Article  CAS  Google Scholar 

  5. Bahtia MJ, Davies SM, Robinson LL . Leukemia. In: Neugut AI, Meadows AT, Robinson E (eds) Multiple Primary Cancers Lippincott Williams & Williams: New York 1999 257–276

    Google Scholar 

  6. Laughlin MJ, McGaughey DS, Crews JR, Chao NJ, Rizzieri D, Ross D, Gockerman J, Cirrincione C, Berry D, Mills L, Defusco P, Legrand S, Peters WP, Vredenburg JJ . Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant J Clin Oncol 1998 16: 1008–1012

    Article  CAS  Google Scholar 

  7. Kumpulainen EJ, Hirvikoski PP, Pukkala E, Johansson RT . Cancer risk after adjuvant chemo- or chemohormonal therapy of breast cancer Anticancer Drugs 1998 9: 131–134

    Article  CAS  Google Scholar 

  8. Linassier C, Barin C, Bremond JL . Secondary leukaemia in breast cancer patients after exposure to an association of mitoxantrone, fluorouracil, cyclophosphamide and radiotherapy Proc Am Soc Clin Oncol 1996 15: 360–363

    Google Scholar 

  9. Pedersen Bjergaard J, Sigsgaard TC, Nielsen D, Gjedde SB, Philip P, Hansen M, Larsen O, Mouridsen H, Dombernowsky P . Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer J Clin Oncol 1992 10: 1444–1451

    Article  CAS  Google Scholar 

  10. Carli PM, Milan C, Lange A, Devilliers E, Guy H, Faivre J . Haematopoietic malignancies in Côte d'Or (France): a population based study Br J Cancer 1986 53: 811–815

    Article  CAS  Google Scholar 

  11. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposals for the classification of the myelodysplastic syndromes Br J Haematol 1982 51: 189–199

    Article  CAS  Google Scholar 

  12. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French–American–British Cooperative Group Ann Intern Med 1985 103: 620–625

    Article  CAS  Google Scholar 

  13. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield C . World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting, Airlie House, Virginia, November, 1997 J Clin Oncol 1999 17: 3835–3849

    Article  CAS  Google Scholar 

  14. Mitelman F, Kargers S, Basel P . An International System for Human Cytogenetic Nomenclature ISCN 1995

    Google Scholar 

  15. Smith MA, Rubinstein L, Ungerleider RS . Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks Med Ped Oncol 1994 23: 86–98

    Article  CAS  Google Scholar 

  16. Dissing M, Le Beau MM, Pedersen Bjergaard J . Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors? J Clin Oncol 1998 16: 1890–1896

    Article  CAS  Google Scholar 

  17. Hoffmann L, Mö P, Pedersen Bjergaard J, Waage A, Pedersen M, Hirsch FR . Therapy-related acute promyelocytic leukemia with t(15;17)(q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature Ann Oncol 1995 6: 781–788

    Article  CAS  Google Scholar 

  18. Detourmignies L, Castaigne S, Stoppa AM, Harousseau JL, Sadoun A, Janvier M, Demory JL, Sanz M, Berger R, Bauters F . Therapy-related acute promyelocytic leukemia: a report on 16 cases J Clin Oncol 1992 10: 1430–1435

    Article  CAS  Google Scholar 

  19. Curtis RE, Boice JD Jr, Stovall M, Bernstein L, Greenberg RS, Flamery JT, Schwartz AG, Weyer P, Moloney WC, Hoover RN . Risk of leukemia after chemotherapy and radiation treatment for breast cancer New Engl J Med 1992 326: 1745–1751

    Article  CAS  Google Scholar 

  20. Ellis M, Ravid M, Lishner M . A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias Leuk Lymphoma 1993 11: 9–13

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr M Flesch and Dr F Bailly for their contributions to the Registre des Hémopathies Malignes de la Côte d'Or.

Author information

Authors and Affiliations

  1. Registre des Hémopathies Malignes de la Côte d'Or, Faculté de Médecine de Dijon, France

    PM Carli, F Girodon & M Maynadié

  2. Centre Régional de Pharmacovigilance, Hôpital Général, Dijon, France

    C Sgro & N Parchin-Geneste

  3. Service d'Hématologie Clinique, Hôpital d'Enfants, Dijon, France

    N Isambert

  4. Laboratoire de Cytogénétique, Hôpital du Bocage, Dijon, France

    F Mugneret

Authors
  1. PM Carli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Sgro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N Parchin-Geneste
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N Isambert
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F Mugneret
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F Girodon
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Maynadié
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carli, P., Sgro, C., Parchin-Geneste, N. et al. Increase therapy-related leukemia secondary to breast cancer. Leukemia 14, 1014–1017 (2000). https://doi.org/10.1038/sj.leu.2401787

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401787

Keywords

This article is cited by

Search

Advanced search

Quick links